About Uncharacterized protein C16orf96
Uncharacterized protein C16orf96 (C16orf96) is a protein
from Homo sapiens identified by UniProt accession
A6NNT2, 1141 residues long.
MolForge cross-references it against 0 known binders and
21 disease associations.
Target properties
| Protein name | Uncharacterized protein C16orf96 |
|---|
| UniProt accession | A6NNT2 |
|---|
| Gene | C16orf96 |
|---|
| Organism | Homo sapiens |
|---|
| Length | 1141 residues |
|---|
| Molecular weight | — |
|---|
| EC numbers | — |
|---|
| Target class | UNCLASSIFIED |
|---|
| Subcellular location | — |
|---|
| Keywords | — |
|---|
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
|---|
| Druggability score | — |
|---|
| Pocket score | — |
|---|
| Max clinical phase | — |
|---|
Disease associations (21)
Diseases linked to this target (Open Targets).
- BMI-adjusted waist circumference · score 0.31
- platelet count · score 0.27
- vital capacity · score 0.20
- triglyceride measurement · score 0.20
- monocyte percentage of leukocytes · score 0.14
- mean corpuscular hemoglobin concentration · score 0.14
- urate measurement · score 0.14
- sex hormone-binding globulin measurement · score 0.11
- platelet crit · score 0.11
- IGF-1 measurement · score 0.08
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
|---|
| AF-A6NNT2-F1 | alphafold | PREDICTED | 55.53 | — |
Amino-acid sequence (1141 residues)
MSFSLTFTEL ANIAIPQCGV LNFKALHLLL HGILEHIHMA ELKKVLSGDE DFLQTSQVVI MPREGDAQPI LNPMKRLSNV FDHVVSRLDK LENQLALLQD LPSTAQLLEA SQGTARPVQD LWHLIKLRKM VEGHDEVMAK SMQTLQDLLT DLHALQVTIT ALRKEVDMLK NMLDKVHPER MDIFAEDFKI QNWKMVALQR EVASLQNKFK TIPKTEDMVL WSGLHDAMFT SEIGSSPLDL WQSVEQLPEA ALAQTTKYLE ATRAIQVSEP VQNPQLLQTV WHYEVPELLP EGSSAQAVSL SRAQEPAQPP ALTPESAPGC TTEFAPGPAP GTEPVPGLEL GLELEPVPAL GPVPGPSVTP GSLPAPWPVL GPVPAPGAQP PPLGDWPALP RRWPLPQGWP RVGSWPLWDL GVLRPTQPQP SRAPPPATEF GSLWPRPLQP YQSRQGEALQ LAAVQVKGEE NDVPSLRGLR ERARKDGAPK DRTRKDGVPK DRGGKDVDPK DRAHKDDVPK DRGGKDVDPK DRAHKDDVPK DRGGKDGDPK DRVGKDGAPK EAQPKAPQSA LHRLKTTAAI AAAAAAAYAA ATSSAAQAAK VAAKFVKDAP ATKMAAIATD TAAAGPLGVF ADVLGAGPSR GATESQILGD DSEIYEILSP SYSAASIGPD PALSQAMVAT KQAMSPEDKK RAVKYSMSHI AQIPVKHDSL KEEFAQLSCN LNQRLSYLAN MGGPSSLGTT VDILQKKIGS LQKSRLKEEE LERIWGNQIE MMKDRYITLD KAVENLQIRM DEFKTLQAQI KRLEMNKVNK STMEEELREK ADRSALAGKA SRVDLETVAL ELNEMIQGIL FKVTIHEDSW KKAMEELSKD VNTKLVHSDL DPLKKEMEEV WKIVRKLLIE GLRLDPDSAA GFRRKLFKRV KCISCDRPVE MMTGPQLITI RKAHLLSRLR PASANSCEYL QRQQMREQQW LQLQDLGIQE DCQQDWGDGP QNATSLKCKS CNLLTLYPYG DPHVIDYDSA EVDILGVDGI LYKGRVNSQR GAQPLAVAKE LAAVKAPSPP SQSLYDRVHS SALFGAICPP LCPRSSACSA ASGPHLTMPA RPPSLPPLLL LPPLIPSLRD PQQAPGSTRL SRAPHIESRV GRKPPEEPAN P
Explore Uncharacterized protein C16orf96 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets